Search for: "Eli Lilly and Company Inc"
Results 61 - 80
of 411
Sort by Relevance
|
Sort by Date
18 Apr 2017, 6:52 am
Eli Lilly & Co., 598 F.3d 1336, 1352-53 (Fed. [read post]
12 Apr 2017, 10:32 am
Indianapolis, Indiana – Eli Lilly and Company of Indianapolis, Indiana filed a federal lawsuit in the Southern District of Indiana alleging patent infringement. [read post]
12 Apr 2017, 10:32 am
Indianapolis, Indiana – Eli Lilly and Company of Indianapolis, Indiana filed a federal lawsuit in the Southern District of Indiana alleging patent infringement. [read post]
11 Apr 2017, 3:01 pm
CSR now encompasses not only what companies do with their profits, but also how they make them in virtually every respect of their operations. [read post]
10 Apr 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
6 Apr 2017, 1:35 pm
The initial text of the decision in The Medicines Company v. [read post]
3 Apr 2017, 1:00 am
On Tuesday 4 April until Thursday 6 April, the Supreme Court will hear the appeal of Eli Lilly & Co v Actavis UK Ltd & Ors, and other cases. [read post]
24 Feb 2017, 12:04 pm
Boston University Journal of Science and Technology Law Symposium Sorry, guys, I did not follow the patent panels.Panel III: Trademarks Rebecca Tushnet, Fixing Incontestability: The Next FrontierIncontestability is a nearly unique feature of American trademark law, with a unique American implementation. [read post]
24 Feb 2017, 11:52 am
Indianapolis, Indiana – The matter of Eli Lilly and Company, et al. v. [read post]
23 Feb 2017, 12:16 pm
Indianapolis, Indiana – A patent lawyer for Eli Lilly and Company of Indianapolis, Indiana, Eli Lilly Export S.A. of Geneva, Switzerland and Acrux DDS, Pty Ltd. of West Melbourne, Australia filed an intellectual property lawsuit in the Southern District of Indiana. [read post]
23 Jan 2017, 12:41 pm
In the case of Eli Lilly and Company v. [read post]
23 Jan 2017, 12:41 pm
In the case of Eli Lilly and Company v. [read post]
29 Dec 2016, 12:36 pm
Indianapolis, Indiana – Eli Lilly and Company of Indianapolis, Indiana filed a lawsuit in the Southern District of Indiana alleging patent infringement. [read post]
31 Oct 2016, 11:33 am
Indianapolis, Indiana - Patent lawyers for Plaintiffs Eli Lilly and Company of Indianapolis, Indiana, its subsidiary Eli Lilly Export S.A. of Geneva, Switzerland and Acrux DDS Pty Ltd of West Melbourne, Australia filed a lawsuit alleging patent infringement. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
17 Jul 2016, 9:56 pm
Eli Lilly and Company et al. v. [read post]
8 Jul 2016, 10:51 am
Indianapolis, Indiana - Patent lawyers for Plaintiffs Eli Lilly and Company of Indianapolis, Indiana, Eli Lilly Export S.A. of Geneva, Switzerland and Acrux DDS Pty Ltd. of West Melbourne, Australia initiated patent infringement litigation in the Southern District of Indiana. [read post]
20 Jun 2016, 9:10 am
Reg.48697–48698.This inconsistency had been an argument for those supporting the Cuozzo position; Reuters noted:Cuozzo was supported by several industry groups and companies, which urged the justices to take the case.One friend-of-the-court brief filed in the case on behalf of 3M Co, Caterpillar Inc, Eli Lilly and Co and Qualcomm Inc said the patent office reviews and litigation in district court needed to be streamlined for the "proper… [read post]
16 Jun 2016, 9:59 pm
Today, we review the amici curiae brief submitted by Eli Lilly and Company, Eisai Inc., Upsher-Smith Labroatories, Inc., Pfizer Inc.,... [read post]
9 May 2016, 4:00 am
Eli Lilly and Co., 2004 FCA 232 at para 15) Much of the commentary on these new guidelines have focused on their application to pharmaceuticals. [read post]
